Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Italfarmaco SA

Division of Italfarmaco SPA
www.itfsp.com

Latest From 3SBio-TNK Joint Venture

AstraZeneca Divests Antidiabetics To 3SBio In New China Growth Plan

AstraZeneca has out-licensed Chinese commercial rights to four antidiabetics to Shenyang’s 3SBio, reflecting the UK firm's increasing focus on its core respiratory franchise and new products, while 3SBio is looking to expand into new areas.

Commercial Metabolic Disorders
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Spain
  • Parent & Subsidiaries
  • Italfarmaco SPA
  • Senior Management
  • Contact Info
  • Italfarmaco SA
    Phone: (34) 91 657 23 23
    Poligono Industrial de Alcobendas
    San Rafael 3
    Alcobendas, 28108
    Spain
Advertisement
Advertisement
UsernamePublicRestriction

Register